ALPS Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20,338
Closed -$1.62M 939
2021
Q3
$1.62M Sell
20,338
-1,406
-6% -$121K 0.02% 340
2021
Q2
$2.12M Sell
21,744
-6,235
-22% -$738K 0.02% 319
2021
Q1
$3.27M Buy
27,979
+75
+0.3% +$8.74K 0.03% 207
2020
Q4
$3.1M Buy
27,904
+8,222
+42% +$1M 0.03% 210
2020
Q3
$2.34M Sell
19,682
-1,365
-6% -$148K 0.03% 215
2020
Q2
$2.38M Sell
21,047
-7,006
-25% -$689K 0.03% 221
2020
Q1
$1.87M Sell
28,053
-2,967
-10% -$247K 0.03% 219
2019
Q4
$2.83M Buy
31,020
+263
+0.9% +$25.5K 0.02% 199
2019
Q3
$2.65M Sell
30,757
-1,516
-5% -$142K 0.02% 192
2019
Q2
$3.38M Sell
32,273
-4,907
-13% -$526K 0.03% 178
2019
Q1
$4.66M Buy
37,180
+1,608
+5% +$200K 0.03% 173
2018
Q4
$4.01M Buy
35,572
+8,378
+31% +$1.3M 0.03% 171
2018
Q3
$5.82M Buy
27,194
+6,615
+32% +$1.66M 0.04% 152
2018
Q2
$5.76M Buy
20,579
+1,800
+10% +$316K 0.04% 161
2018
Q1
$2.19M Buy
18,779
+4,932
+36% +$609K 0.02% 206
2017
Q4
$1.27M Buy
+13,847
New +$791K 0.01% 224

Other funds holding MDGL